Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Therapeutic Effects of Various Initial Combination Chemotherapy Including Clarithromycin Against Mycobacterium avium Complex Pulmonary Disease
Chest, 06/26/09
Hasegawa N et al. - The higher dose of CAM allowed better culture conversion. Daily combination chemotherapy including CAM 800mg seems appropriate as initial treatment against treatment-naive nodular and bronchiectatic MAC pulmonary disease.
Related Articles
Clarithromycin Resistance and Efficacy of Clarithromycin-Containing Triple Eradication Therapy for Helicobacter pylori Infection in Type 2 Diabetes Mellitus Patients
Southern Medical Journal, 11/09/09
Relevance Score: 87%
Clarithromycin–Amoxycillin-Containing Triple Therapy: A Valid Empirical First-Line Treatment for Helicobacter pylori Eradication in Hong Kong
Helicobacter, 11/09/09
Relevance Score: 87%
Physiologically-Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Drug Metabolism and Disposition, 11/06/09
Relevance Score: 87%
Analysis of Clarithromycin Resistance and CagA Status in Helicobacter pylori Using Feces from Children in Thailand
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 87%
Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine
European Journal of Pain, 11/10/09
Relevance Score: 85%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme
HIV Medicine, 12/11/09
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09
Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics
Transplant Infectious Disease, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


